Clinical Trials Directory

Trials / Unknown

UnknownNCT04831619

Contribution of PET (Positron Emission Tomography) Scans for the Preoperative Assessment of Symptomatic Endometriosis Lesions: TEP-ENDORUN

Contribution of PET Scans for the Preoperative Assessment of Symptomatic Endometriosis Lesions: TEP-ENDORUN

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
10 (estimated)
Sponsor
Centre Hospitalier Universitaire de la Réunion · Academic / Other
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

Endometriosis is an inflammatory condition that is often treated by surgery. MRI and ultrasound are used for the preoperative morphological assessment. Currently, only surgery allows the exhaustive and qualitative diagnosis of lesions. The PET scan, fixing in certain inflammatory pathologies and in certain cases of endometriosis, could refine this assessment by evaluating the location of the lesions.

Conditions

Interventions

TypeNameDescription
DRUGPET scanner with injection of 18 FDG (18F-2-fluoro-2-deoxy-D-glucose) (radiolabel)A PET scan will be performed in the patients included, in addition to the conventional imaging workup (MRI, endovaginal and pelvic ultrasound).

Timeline

Start date
2022-05-01
Primary completion
2023-05-01
Completion
2024-09-30
First posted
2021-04-05
Last updated
2022-03-02

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT04831619. Inclusion in this directory is not an endorsement.

Contribution of PET (Positron Emission Tomography) Scans for the Preoperative Assessment of Symptomatic Endometriosis Le (NCT04831619) · Clinical Trials Directory